MedTrace Logo

Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment

NCT01423799 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-11-13

No results posted yet for this study

Summary

The purpose of this study is to compare the health-related quality of life following dietary supplementation with an immunonutrition formulation vs an isocaloric/isoprotein control diet supplement in patients suffering from upper digestive tract neoplasia undergoing oncological treatment.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nutritional supplements containing arginine, n-3 and nucleotides

Nutritional intervention with immuno-nutrients

DIETARY_SUPPLEMENT

Isocaloric control

Isocaloric and isonitrogenous control without immuno nutrients

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Christophe Mariette, MD · University Hospital Claude Huriez, CHRU-Place de Verdun-59037 Lille, Cedex France

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01423799 on ClinicalTrials.gov